AU2001269640B2 - Vaccine against the influenza virus and method for producing said virus vaccine - Google Patents

Vaccine against the influenza virus and method for producing said virus vaccine Download PDF

Info

Publication number
AU2001269640B2
AU2001269640B2 AU2001269640A AU2001269640A AU2001269640B2 AU 2001269640 B2 AU2001269640 B2 AU 2001269640B2 AU 2001269640 A AU2001269640 A AU 2001269640A AU 2001269640 A AU2001269640 A AU 2001269640A AU 2001269640 B2 AU2001269640 B2 AU 2001269640B2
Authority
AU
Australia
Prior art keywords
influenza virus
heterochain
derivatives
polyamines
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2001269640A
Other languages
English (en)
Other versions
AU2001269640A1 (en
Inventor
Alberta Sergeevna Ivanova
Rakhim Musaevich Khaitov
Arkady Vasilievich Nekrasov
Rem Viktorovich Petrov
Natalya Grigorievna Puchkova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Obschestvo S Ogranichennoj Otvetstvennostju "npo Petrovax Pharm"
Original Assignee
ALBERTA IVANOVA
ARKADY NEKRASOV
NATALYA PUCHKOVA
RAKHIM KHAITOV
REM PETROV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ALBERTA IVANOVA, ARKADY NEKRASOV, NATALYA PUCHKOVA, RAKHIM KHAITOV, REM PETROV filed Critical ALBERTA IVANOVA
Publication of AU2001269640A1 publication Critical patent/AU2001269640A1/en
Application granted granted Critical
Publication of AU2001269640B2 publication Critical patent/AU2001269640B2/en
Assigned to Obschestvo S Ogranichennoj Otvetstvennostju "NPO Petrovax Pharm" reassignment Obschestvo S Ogranichennoj Otvetstvennostju "NPO Petrovax Pharm" Request for Assignment Assignors: Ivanova, Alberta, Khaitov, Rakhim, Nekrasov, Arkady, PETROV, REM, Puchkova, Natalya
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU2001269640A 2000-08-09 2001-06-13 Vaccine against the influenza virus and method for producing said virus vaccine Ceased AU2001269640B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2000120902 2000-08-09
RU2000120902/14A RU2164148C1 (ru) 2000-08-09 2000-08-09 Вакцина против вируса гриппа и способ ее получения
PCT/RU2001/000229 WO2002011758A1 (fr) 2000-08-09 2001-06-13 Vaccin contre le virus de la grippe et procede de fabrication correspondant

Publications (2)

Publication Number Publication Date
AU2001269640A1 AU2001269640A1 (en) 2002-05-16
AU2001269640B2 true AU2001269640B2 (en) 2005-12-22

Family

ID=20238868

Family Applications (2)

Application Number Title Priority Date Filing Date
AU6964001A Pending AU6964001A (en) 2000-08-09 2001-06-13 Vaccine against the influenza virus and method for producing said virus vaccine
AU2001269640A Ceased AU2001269640B2 (en) 2000-08-09 2001-06-13 Vaccine against the influenza virus and method for producing said virus vaccine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU6964001A Pending AU6964001A (en) 2000-08-09 2001-06-13 Vaccine against the influenza virus and method for producing said virus vaccine

Country Status (5)

Country Link
KR (1) KR100568013B1 (ko)
CN (1) CN1464789B (ko)
AU (2) AU6964001A (ko)
RU (1) RU2164148C1 (ko)
WO (1) WO2002011758A1 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2428991C9 (ru) 2010-06-24 2011-12-27 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НПО Петровакс Фарм" Сополимеры гетероцепных алифатических поли-n-оксидов, вакцинирующие и лекарственные средства на их основе
RU2446824C2 (ru) * 2010-07-20 2012-04-10 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения и социального развития Российской Федерации Вакцина против гриппа и способ ее получения
JP6248040B2 (ja) * 2011-09-30 2017-12-13 メディカゴ インコーポレイテッド 植物における増加するウイルス様粒子収量
RU2740751C1 (ru) * 2019-08-28 2021-01-20 Общество с ограниченной ответственностью "Развитие БиоТехнологий" Способ получения тетравалентной субъединичной противогриппозной вакцины

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1580617A1 (ru) * 1988-05-13 1997-02-10 Институт иммунологии Способ получения вакцины против вируса гриппа
RU2073031C1 (ru) * 1990-08-06 1997-02-10 Некрасов Аркадий Васильевич Производные поли-1,4-этиленпиперазина, обладающие иммуномодулирующей, противовирусной и антибактериальной активностями
RU2112542C1 (ru) * 1997-02-28 1998-06-10 Аркадий Васильевич Некрасов Препарат для лечения патологических состояний соединительной ткани
RU2153354C1 (ru) * 1999-03-31 2000-07-27 Московский городской научно-практический центр борьбы с туберкулезом Вакцина против туберкулеза

Also Published As

Publication number Publication date
AU6964001A (en) 2002-02-18
CN1464789B (zh) 2010-12-01
WO2002011758A1 (fr) 2002-02-14
KR100568013B1 (ko) 2006-04-05
KR20030059096A (ko) 2003-07-07
CN1464789A (zh) 2003-12-31
RU2164148C1 (ru) 2001-03-20
WO2002011758A8 (fr) 2003-07-24

Similar Documents

Publication Publication Date Title
EP0186576B1 (en) Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates
JP5745221B2 (ja) タンパク質マトリックスワクチンおよびそのようなワクチンの製造方法および投与方法
EP0467714A1 (en) The class II protein of the outer membrane of neisseria meningitidis
JP4743928B2 (ja) 処方物
JP6072777B2 (ja) ポリカチオンを含むタンパク質マトリックスワクチン組成物
JP2010265330A6 (ja) 処方物
US5019383A (en) Fatty acid carriers for synthetic peptides
US11246919B2 (en) Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria
US6436407B1 (en) Mutant enterotoxin effective as a non-toxic adjuvant
CN104507496B (zh) 包含与crm197载体蛋白偶联的hiv gp41肽的免疫原性化合物
CN107029225B (zh) 一种缀合疫苗及其制备方法
AU2001269640B2 (en) Vaccine against the influenza virus and method for producing said virus vaccine
SK280919B6 (sk) Spôsob výroby kompozitnej vakcíny proti črevnej infekcii spôsobenej enterotoxigénnymi baktériami e. coli u ľudí
US20230372466A1 (en) Universal mammalian influenza vaccine
Ogrina et al. Bacterial expression systems based on Tymovirus-like particles for the presentation of vaccine antigens
JPH05506234A (ja) ワクチン組成物
JPH11507545A (ja) 免疫原性構築物、その製造方法、およびワクチンとしてのその用途
CA2532881A1 (en) Anthrax vaccine
CN107007829B (zh) 一种肺炎多价结合疫苗及其制备方法
CN107050444B (zh) 轮状病毒多糖-蛋白结合疫苗及其制备方法
JP2001505763A (ja) Ｈｉｖ ｐ―１７ペプチドフラグメント、それを含有する組成物並びにその製造及び使用方法
JPH0616569A (ja) 免疫学的担体特性および免疫促進特性を有するナイセリア・メニンギチジスの外膜のクラスｉｉ蛋白、およびそれを含むワクチン
WO1998032461A1 (en) Mutant enterotoxin effective as a non-toxic adjuvant for hiv
CN114057847A (zh) 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途
CN114057853A (zh) 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: OBSCHESTVO S OGRANICHENNOJ OTVETSTVENNOSTJU "NPO P

Free format text: FORMER OWNER WAS: PETROV, REM; NEKRASOV, ARKADY; IVANOVA, ALBERTA; KHAITOV, RAKHIM; PUCHKOVA, NATALYA

MK14 Patent ceased section 143(a) (annual fees not paid) or expired